HCWB (HCW Biologics) EV-to-FCF : -1.37 (As of Mar. 19, 2025)

HCW Biologics EV-to-FCF Chart

HCW Biologics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EV-to-FCF	Get a 7-Day Free Trial															-2.54	-1.63	-2.47	-1.49	-1.68

Competitive Comparison of HCW Biologics's EV-to-FCF

For the Biotechnology subindustry, HCW Biologics's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HCW Biologics's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HCW Biologics's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where HCW Biologics's EV-to-FCF falls into.

HCW Biologics EV-to-FCF Calculation

HCW Biologics's EV-to-FCF for today is calculated as:

HCW Biologics's current Enterprise Value is $26.28 Mil.
HCW Biologics's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-19.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HCW Biologics  (NAS:HCWB) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

HCW Biologics's PE Ratio (TTM) for today is calculated as:

HCW Biologics's share price for today is $0.32.
HCW Biologics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

HCW Biologics EV-to-FCF Related Terms

Thank you for viewing the detailed overview of HCW Biologics's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

HCW Biologics Business Description